​

UnitedHealth Group (UNH) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

UNH Stock Forecast

UnitedHealth Group (UNH) stock forecast, based on 51 Wall Street analysts, predicts a 12-month average price target of $355.08, with a high of $575.00 and a low of $198.00. This represents a 0.42% increase from the last price of $353.61.

$150 $250 $350 $450 $550 $650 High: $575 Avg: $355.08 Low: $198 Last Closed Price: $353.61

UNH Stock Rating

UnitedHealth Group stock's rating consensus is Buy, based on 51 Wall Street analysts. The breakdown includes 1 Strong Buy (1.96%), 40 Buy (78.43%), 6 Hold (11.76%), 4 Sell (7.84%), and 0 Strong Sell (0.00%).

Buy
Total 51 4 6 40 1 Strong Sell Sell Hold Buy Strong Buy

UNH Price Target Upside V Benchmarks

TypeNameUpside
StockUnitedHealth Group0.42%
SectorHealthcare Stocks 13.55%
IndustryHealthcare Plans Stocks22.39%

Price Target Trends

1M3M12M
# Anlaysts5824
Avg Price Target$356.60$335.38$456.25
Last Closing Price$353.61$353.61$353.61
Upside/Downside0.85%-5.16%29.03%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Sep, 2561352-26
Aug, 2561352-26
Jul, 2551361126
Jun, 2561451127
May, 256183--27
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 10, 2025Morgan Stanley$325.00$346.78-6.28%-8.09%
Sep 09, 2025Truist Financial$365.00$347.924.91%3.22%
Sep 05, 2025Bernstein$379.00$315.3920.17%7.18%
Sep 04, 2025Andrew MokBarclays$352.00$310.3813.41%-0.46%
Sep 04, 2025Andrew MokBarclays$362.00$307.8817.58%2.37%
Jul 31, 2025Robert W. Baird$198.00$266.04-25.58%-44.01%
Jul 30, 2025Piper Sandler$317.00$266.0419.16%-10.35%
Jun 25, 2025UBS$385.00$302.0227.48%8.88%
May 21, 2025Sidharth SahooHSBC$270.00$302.98-10.89%-23.64%
May 20, 2025Justin LakeWolfe Research$390.00$321.5821.28%10.29%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Sep 05, 2025BernsteinOutperformOutperformhold
Sep 04, 2025BarclaysOverweightOverweighthold
Aug 04, 2025Wells FargoOverweightOverweighthold
Jul 30, 2025Piper SandlerOverweightOverweighthold
Jul 17, 2025UBSBuyBuyhold
Jun 25, 2025UBSBuyBuyhold
Jun 06, 2025Piper SandlerOverweightOverweighthold
Jun 02, 2025KeyBancNegativeNegativehold
May 21, 2025HSBCHoldReducedowngrade
May 20, 2025Wolfe ResearchOutperformOutperformhold

Financial Forecast

EPS Forecast

$15 $23 $31 $39 $47 $55 Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$16.28$18.33$21.54$24.12$15.51-----
Avg Forecast$16.74$18.84$22.02$24.96$27.61$29.72$33.50$38.08$43.85$50.63
High Forecast$17.04$19.18$22.77$25.02$27.79$30.08$34.27$39.69$44.83$51.76
Low Forecast$16.40$18.46$21.33$24.87$27.30$28.45$32.22$35.72$42.05$48.55
Surprise %-2.75%-2.71%-2.18%-3.37%-43.82%-----

Revenue Forecast

$250B $340B $430B $520B $610B $700B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$255.64B$285.27B$322.13B$367.53B$400.28B-----
Avg Forecast$256.44B$286.74B$323.88B$369.14B$400.99B$450.84B$486.57B$522.61B$589.76B$675.82B
High Forecast$260.00B$290.73B$332.33B$370.46B$402.87B$453.61B$497.97B$523.71B$599.90B$687.44B
Low Forecast$252.46B$282.29B$316.03B$367.79B$400.03B$441.53B$469.85B$521.51B$571.09B$654.43B
Surprise %-0.31%-0.51%-0.54%-0.44%-0.18%-----

Net Income Forecast

$5B $14B $23B $32B $41B $50B Dec 20 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 20Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$15.40B$17.29B$20.12B$22.38B$14.40B-----
Avg Forecast$12.47B$15.70B$17.98B$22.38B$25.59B$27.19B$30.89B$35.03B$40.74B$47.04B
High Forecast$14.97B$18.84B$21.58B$26.86B$25.81B$27.95B$31.83B$36.87B$41.65B$48.09B
Low Forecast$9.98B$12.56B$14.39B$17.90B$25.36B$26.43B$29.94B$33.18B$39.06B$45.10B
Surprise %23.48%10.10%11.89%--43.70%-----

UNH Forecast FAQ

Is UnitedHealth Group stock a buy?

UnitedHealth Group stock has a consensus rating of Buy, based on 51 Wall Street analysts. The rating breakdown includes 1 Strong Buy, 40 Buy, 6 Hold, 4 Sell, and 0 Strong Sell, reflecting a consensus that UnitedHealth Group is a favorable investment for most analysts.

What is UnitedHealth Group's price target?

UnitedHealth Group's price target, set by 51 Wall Street analysts, averages $355.08 over the next 12 months. The price target range spans from $198 at the low end to $575 at the high end, suggesting a potential 0.42% change from the previous closing price of $353.61.

How does UnitedHealth Group stock forecast compare to its benchmarks?

UnitedHealth Group's stock forecast shows a 0.42% upside, underperforming the average forecast for the healthcare stocks sector (13.55%) and underperforming the healthcare plans stocks industry (22.39%).

What is the breakdown of analyst ratings for UnitedHealth Group over the past three months?

  • September 2025: 23.08% Strong Buy, 50.00% Buy, 19.23% Hold, 7.69% Sell, 0% Strong Sell.
  • August 2025: 23.08% Strong Buy, 50.00% Buy, 19.23% Hold, 7.69% Sell, 0% Strong Sell.
  • July 2025: 19.23% Strong Buy, 50.00% Buy, 23.08% Hold, 3.85% Sell, 3.85% Strong Sell.

What is UnitedHealth Group’s EPS forecast?

UnitedHealth Group's average annual EPS forecast for its fiscal year ending in December 2025 is $29.72, marking a 91.62% increase from the reported $15.51 in 2024. Estimates for the following years are $33.5 in 2026, $38.08 in 2027, $43.85 in 2028, and $50.63 in 2029.

What is UnitedHealth Group’s revenue forecast?

UnitedHealth Group's average annual revenue forecast for its fiscal year ending in December 2025 is $450.84B, reflecting a 12.63% increase from the reported $400.28B in 2024. The forecast for 2026 is $486.57B, followed by $522.61B for 2027, $589.76B for 2028, and $675.82B for 2029.

What is UnitedHealth Group’s net income forecast?

UnitedHealth Group's net income forecast for the fiscal year ending in December 2025 stands at $27.19B, representing an 88.73% increase from the reported $14.4B in 2024. Projections indicate $30.89B in 2026, $35.03B in 2027, $40.74B in 2028, and $47.04B in 2029.